Zheng, L. Et Al. 2024. Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.. Cellular signalling , vol.124 , 111467.

Zheng, L., Rajamanickam, V., Wang, M., Zhang, H., Fang, S., Linnebacher, M., ... El-Aty, A. M. A.(2024). Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.. Cellular signalling , vol.124, 111467.

Zheng, Liyun Et Al. "Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.," Cellular signalling , vol.124, 111467, 2024

Zheng, Liyun Et Al. "Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.." Cellular signalling , vol.124, pp.111467, 2024

Zheng, L. Et Al. (2024) . "Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.." Cellular signalling , vol.124, p.111467.

@article{article, author={Liyun Zheng Et Al. }, title={Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma.}, journal={Cellular signalling}, year=2024, pages={111467} }